%{search_type} search results

130,242 catalog results

RSS feed for this result
Journal/Periodical
volumes ; 30 cm
SAL3 (off-campus storage)
Book
1 online resource (350 pages).
Book
1 online resource.
  • Foreword Preface Section 1 1.1 Definition, prevalence and historical perspectives of obesity in adults 1.2 Definition, prevalence and historical perspectives of obesity in children 1.3 Development of overweight and obesity across the life course 1.4 Diagnostic Criteria and Assessment of Obesity in Adults 1.5 Diagnostic criteria and assessment of obesity in children Section 2 2.1 Obesity in the development of type 2 diabetes 2.2 Obesity in the development of cardiovascular disease 2.3 Obesity as a risk factor in the development of cancer 2.4 Obesity as a risk factor in osteoarthritis and pulmonary disease 2.5 Psychology and mental health disorders in obesity 2.6 Binge eating and obesity Section 3 3.1 Genetics and epigenetics in the aetiology of obesity 3.2 Food intake and appetite in the aetiology of obesity 3.3 Physiological control of appetite and food intake 3.4 Obesogenic medication in the aetiology of obesity 3.5 GUT MICROBIOME IN OBESITY 3.6 Physical activity and physical inactivity in the aetiology of obesity 3.7 Obesogenic environment and obesogenic behaviours Section 4 4.1 Macronutrient composition for weight loss in obesity 4.2 Meal replacements for weight loss in obesity 4.3 formula diets for weight loss in obesity 4.4 Group-based interventions for weight loss in obesity 4.5 Commercial weight management organisations for weight loss in obesity 4.6 Fad diets and fasting for weight loss in obesity 4.7 Pharmacological management of weight loss in obesity 4.8 Diet to support pharmacological management of weight loss 4.9 Surgical management of weight loss in obesity 4.10 Diet to support surgical management of weight loss 4.11 PHYSICAL ACTIVITY FOR WEIGHT LOSS IN OBESITY 4.12 Psychological interventions for weight loss in obesity 4.13 Weight loss interventions in specific groups: overweight and obese men 4.14 Weight loss interventions in specific groups: intellectual disabilities 4.15 Weight Maintenance following weight loss in obesity 4.16 Economic cost of obesity and the cost effectiveness of weight management Section 5 5.1 Genetics, epigenetics and obesity: focus on studies in children 5.2 Food intake, eating behaviour and obesity in children 5.3 Physical activity and inactivity in the aetiology of obesity in children Section 6 6.1 Diet in the management of weight loss in childhood obesity 6.2 Physical Activity in the management of weight loss in childhood obesity 6.3- Psychological and behavioural interventions in childhood obesity 6.4 Residential programmes and weight loss camps in childhood obesity 6.5 Pharmacological management of weight loss in childhood obesity 6.6 Surgical management of weight loss in childhood obesity Section 7 7.1 National campaigns to modify eating behaviour in the prevention of obesity 7.2 Increasing physical activity to prevent childhood obesity 7.3 Designing public health initiatives for the prevention of obesity Index.
  • (source: Nielsen Book Data)9780470670767 20171211
This addition to the British Dietetic Association Advanced Nutrition and Dietetics book series is written for clinicians and researchers who work with any aspect of obesity and its comorbid conditions. Featuring contributions from leading researchers and practitioners from around the globe Advanced Nutrition and Dietetics in Obesity offers a uniquely international perspective on what has become a worldwide public health crisis. Chapters cover a full range of new ideas and research on the underlying drivers of obesity in populations including discussions on the genetic and clinical aspects of obesity, along with expert recommendations on how to effectively manage and prevent this chronic and persistent disease. Providing a comprehensive overview of the key literature in this field, Advanced Nutrition and Dietetics in Obesity is an invaluable resource for all those whose work should or does embrace any aspect of obesity.
(source: Nielsen Book Data)9780470670767 20171211
Book
xi, 217 pages ; 22 cm
  • Introduction.- Chapter 1: AIDS in the Islamic Republic.- Chapter 2: The HIV prevention market.- Chapter 3: Enterprising bureaucrats.- Chapter 4: Surviving hard times.- Chapter 5: Participating in the Global Fund.- Chapter 6: Responsibility for care and support.- Chapter 7: AIDS activism.- Conclusion.
  • (source: Nielsen Book Data)9789811062193 20171218
This book is the first full-length study of HIV/AIDS work in relation to government and NGOs. In the early 2000s, Pakistan's response to HIV/AIDS was scaled-up and declared an area of urgent intervention. This response was funded by international donors requiring prevention, care and support services to be contracted out to NGOs - a global policy considered particularly important in Pakistan where the high risk populations are criminalized by the state. Based on unparalleled ethnographic access to government bureaucracies and their dealings with NGOs, Qureshi examines how global policies were translated by local actors and how they responded to the evolving HIV/AIDS crisis. The book encourages readers to reconsider the orthodoxy of policies regarding public-private partnership by critiquing the resulting changes in the bureaucracy, civil society and public goods. It is a must-read for students, scholars and practitioners concerned with neoliberal agendas in global health and development.
(source: Nielsen Book Data)9789811062193 20171218
SAL3 (off-campus storage)
Book
1 online resource.
Book
1 online resource.
  • List of Contributors xi Preface xv Acknowledgments xvii Section 1 Introduction to Biosensors, Recognition Elements, Biomarkers, and Nanomaterials 1 1 General Introduction to Biosensors and Recognition Receptors 3Frank Davis and Zeynep Altintas 1.1 Introduction to Biosensors 3 1.2 Enzyme- Based Biosensors 4 1.3 DNA- and RNA-Based Biosensors 5 1.4 Antibody-Based Biosensors 7 1.5 Aptasensors 8 1.6 Peptide-Based Biosensors 10 1.7 MIP-Based Biosensor 11 1.8 Conclusions 12 References 13 2 Biomarkers in Health Care 17Adama Marie Sesay, Pirkko Tervo, and Elisa Tikkanen 2.1 Introduction 17 2.2 Biomarkers 18 2.2.1 Advantage and Utilization of Biomarkers 18 2.2.2 Ideal Characteristics of Biomarkers 19 2.3 Biological Samples and Biomarkers 20 2.4 Personalized Health and Point-of-Care Technology 22 2.5 Use of Biomarkers in Biosensing Technology 24 2.6 Biomarkers in Disease Diagnosis 26 2.7 Conclusions 29 References 30 3 The Use of Nanomaterials and Microfluidics in Medical Diagnostics 35Jon Ashley and Yi Sun 3.1 Introduction 35 3.2 Nanomaterials in Medical Diagnostics (Bottom-Up Approach) 36 3.2.1 Carbon Nanomaterials 37 3.2.2 Metallic Nanoparticles 39 3.2.2.1 Quantum Dots 39 3.2.2.2 Magnetic Nanoparticles (Fe2O3, FeO, and Fe3O4) 41 3.2.2.3 Gold Nanoparticles 41 3.2.2.4 Silver Nanoparticles 42 3.2.2.5 Nanoshells 42 3.2.2.6 Nanocages 43 3.2.2.7 Nanowires 43 3.2.3 Polymer-Based Nanoparticles 44 3.3 Application of Microfluidic Devices in Clinical Diagnostics (Top-Down Approach) 45 3.3.1 Unique Features of Microfluidic Devices 45 3.3.2 Applications of Microfluidic Devices in Medical Diagnostics 46 3.3.2.1 Types of Microfluidic POC Devices 47 3.3.2.2 Benchtop Microfluidic Instruments 47 3.3.2.3 Small, Lightweight Microfluidic Devices 49 3.3.2.4 Simple Un-instrumented Microfluidic Systems 50 3.4 Integration of Microfluidics with Nanomaterials 52 3.5 Future Perspectives of Nanomaterial and Microfluidic-Based Diagnostics 53 References 54 Section 2 Biosensor Platforms for Disease Detection and Diagnostics 59 4 SPR-Based Biosensor Technologies in Disease Detection and Diagnostics 61Zeynep Altintas and Wellington M. Fakanya 4.1 Introduction 61 4.2 Basic Theoretical Principles 63 4.3 SPR Applications in Disease Detection and Diagnostics 66 4.3.1 SPR Biosensors in Cancer Detection 66 4.3.2 SPR Sensors in Cardiac Disease Detection 68 4.3.3 SPR Sensors in Infectious Disease Detection 71 4.4 Conclusions 72 References 74 5 Piezoelectric-Based Biosensor Technologies in Disease Detection and Diagnostics 77Zeynep Altintas and Noor Azlina Masdor 5.1 Introduction 77 5.2 QCM Biosensors 78 5.3 Disease Diagnosis Using QCM Biosensors 80 5.3.1 Cancer Detection Using QCM Biosensors 82 5.3.2 Cardiovascular System Disorder Detection Using Biosensors 85 5.3.3 Pathogenic Disease Detection Using QCM Biosensors 88 5.4 Conclusions 90 References 91 6 Electrochemical-Based Biosensor Technologies in Disease Detection and Diagnostics 95Andrea Ravalli and Giovanna Marrazza 6.1 Introduction 95 6.2 Electrochemical Biosensors: Definitions, Principles, and Classifications 96 6.3 Biomarkers in Clinical Applications 102 6.3.1 Electrochemical Biosensors for Tumor Markers 102 6.3.2 Electrochemical Biosensors for Cardiac Markers 110 6.3.3 Electrochemical Biosensors for Autoimmune Disease 115 6.3.4 Electrochemical Biosensors for Autoimmune Infectious Disease 116 6.4 Conclusions 118 References 118 7 MEMS-Based Cell Counting Methods 125Mustafa Kangul, Eren Aydin, Furkan Gokce, Ozge Zorlu, Ebru Ozgur, and Haluk Kulah 7.1 Introduction 125 7.2 MEMS-Based Cell Counting Methods 126 7.2.1 Optical Cell Counting Methods 126 7.2.1.1 Quantification of the Cells by Detecting Luminescence 127 7.2.1.2 Quantification of the Cells via High-Resolution Imaging Techniques 130 7.3 Electrical and Electrochemical Cell Counting Methods 131 7.3.1 Impedimetric Cell Quantification 133 7.3.2 Voltammetric and Amperometric Cell Quantification 135 7.4 Gravimetric Cell Counting Methods 136 7.4.1 Deflection-Based Cell Quantification 136 7.4.2 Resonant-Based Cell Quantification 138 7.4.2.1 Theory of the Resonant-Based Sensors 138 7.4.2.2 Actuation and Sensing Methods of Resonators in MEMS Applications 140 7.4.2.3 Resonator Structure Types Used for Cell Detection Applications 145 7.5 Conclusion and Comments 149 References 151 8 Lab-on-a-Chip Platforms for Disease Detection and Diagnosis 155Ziya Isiksacan, Mustafa Tahsin Guler, Ali Kalantarifard, Mohammad Asghari, and Caglar Elbuken 8.1 Introduction 155 8.2 Continuous Flow Platforms 156 8.3 Paper-Based LOC Platforms 161 8.4 Droplet-Based LOC Platforms 166 8.5 Digital Microfluidic-Based LOC Platforms 169 8.6 CD-Based LOC Platforms 172 8.7 Wearable LOC Platforms 174 8.8 Conclusion and Outlook 176 References 177 Section 3 Nanomaterial's Applications in Biosensors and Diagnostics 183 9 Applications of Quantum Dots in Biosensors and Diagnostics 185Zeynep Altintas, Frank Davis, and Frieder W. Scheller 9.1 Introduction 185 9.2 Quantum Dots: Optical Properties, Synthesis, and Surface Chemistry 186 9.3 Biosensor Applications of QDs 187 9.4 Other Biological Applications of QDs 191 9.5 Water Solubility and Cytotoxicity 194 9.6 Conclusion 196 References 197 10 Applications of Molecularly Imprinted Nanostructures in Biosensors and Diagnostics 201Deniz Aktas-Uygun, Murat Uygun, and Sinan Akgol 10.1 Introduction 201 10.2 Molecular Imprinted Polymers 202 10.3 Imprinting Approaches 204 10.4 Molecularly Imprinted Nanostructures 205 10.5 MIP Biosensors in Medical Diagnosis 207 10.6 Diagnostic Applications of MIP Nanostructures 210 10.7 Conclusions 212 References 213 11 Smart Nanomaterials: Applications in Biosensors and Diagnostics 219Frank Davis, Flavio M. Shimizu, and Zeynep Altintas 11.1 Introduction 219 11.2 Metal Nanoparticles 221 11.3 Magnetic Nanoparticles 226 11.4 Carbon Nanotubes 231 11.5 Graphene 235 11.6 Nanostructured Metal Oxides 242 11.7 Nanostructured Hydrogels 247 11.8 Nanostructured Conducting Polymers 254 11.9 Conclusions and Future Trends 260 References 262 12 Applications of Magnetic Nanomaterials in Biosensors and Diagnostics 277Zeynep Altintas 12.1 Introduction 277 12.2 MNP-Based Biosensors for Disease Detection 279 12.3 MNPs in Cancer Diagnosis and Therapy 284 12.4 Cellular Applications of MNPs in Biosensing, Imaging, and Therapy 289 12.5 Conclusions 290 References 291 13 Graphene Applications in Biosensors and Diagnostics 297Adina Arvinte and Adama Marie Sesay 13.1 Introduction 297 13.2 Graphene and Biosensors 298 13.2.1 Structure 298 13.2.2 Preparation 299 13.2.3 Properties 301 13.2.4 Commercialization in the Field of Graphene Sensors 302 13.2.5 Latest Developments in Graphene-based Diagnosis 303 13.3 Medical Applications of Graphene 303 13.3.1 Electrochemical Graphene Biosensors for Medical Diagnostics 304 13.3.1.1 Glucose Detection 304 13.3.1.2 Cysteine Detection 307 13.3.1.3 Cholesterol Detection 309 13.3.1.4 Hydrogen Peroxide (H2O2) 310 13.3.1.5 Glycated Hemoglobin 312 13.3.1.6 Neurotransmitters 312 13.3.1.7 Amyloid-Beta Peptide 315 13.3.2 Electrochemical Graphene Aptasensors 316 13.3.2.1 Nucleic Acids 316 13.3.2.2 Cancer Cell 318 13.3.3 Optical Graphene Sensors for Medical Diagnostics 319 13.4 Conclusions 322 Acknowledgments 322 References 322 Section 4 Organ-Specific Health Care Applications for Disease Cases Using Biosensors 327 14 Optical Biosensors and Applications to Drug Discovery for Cancer Cases 329Zeynep Altintas 14.1 Introduction 329 14.2 Biosensor Technology and Coupling Chemistries 332 14.3 Optical Biosensors for Drug Discovery 335 14.4 Computational Simulations and New Approaches for Drug-Receptor Interactions 341 14.5 Conclusions 343 References 344 15 Biosensors for Detection of Anticancer Drug-DNA Interactions 349Arzum Erdem, Ece Eksin, and Ece Kesici 15.1 Introduction 349 15.2 Electrochemical Techniques 351 15.3 Optical Techniques 356 15.4 Electrochemical Impedance Spectroscopy Technique 358 15.5 QCM Technique 360 15.6 Conclusions 361 Acknowledgments 361 References 361 Index.
  • (source: Nielsen Book Data)9781119065012 20171204
Provides a broad range of information from basic principles to advanced applications of biosensors and nanomaterials in health care diagnostics This book utilizes a multidisciplinary approach to provide a wide range of information on biosensors and the impact of nanotechnology on the development of biosensors for health care. It offers a solid background on biosensors, recognition receptors, biomarkers, and disease diagnostics. An overview of biosensor-based health care applications is addressed. Nanomaterial applications in biosensors and diagnostics are included, covering the application of nanoparticles, magnetic nanomaterials, quantum dots, carbon nanotubes, graphene, and molecularly imprinted nanostructures. The topic of organ-specific health care systems utilizing biosensors is also incorporated to provide deep insight into the very recent advances in disease diagnostics. Biosensors and Nanotechnology: Applications in Health Care Diagnostics is comprised of 15 chapters that are presented in four sections and written by 33 researchers who are actively working in Germany, the United Kingdom, Italy, Turkey, Denmark, Finland, Romania, Malaysia and Brazil. It covers biomarkers in healthcare; microfluidics in medical diagnostics; SPR-based biosensor techniques; piezoelectric-based biosensor technologies; MEMS-based cell counting methods; lab-on-chip platforms; optical applications for cancer cases; and more. Discusses the latest technology and advances in the field of biosensors and their applications for healthcare diagnosticsParticular focus on biosensors for cancerSummarizes research of the last 30 years, relating it to state-of-the-art technologies Biosensors and Nanotechnology: Applications in Health Care Diagnostics is an excellent book for researchers, scientists, regulators, consultants, and engineers in the field, as well as for graduate students studying the subject.
(source: Nielsen Book Data)9781119065012 20171204
Book
1 online resource (xxi, 1714 pages) : illustrations (chiefly color)
  • Section 1: History of the Therapy of Breast Cancer 1. History of the Therapy of Breast Cancer Section 2: Anatomy and Physiology of the Normal and Lactating Breast 2. Anatomy of the Breast, Axilla, Chest Wall, and Related Metastatic Sites 3. Breast Physiology: Normal and Abnormal Development and Function 4. Discharges and Secretions of the Nipple Section 3: Benign and Premalignant Lesions 5. Etiology and Management of Benign Breast Disease 6. Mastitis and Breast Abscess 7. Gynecomastia 8. Benign, High-Risk, and Premalignant Lesions of the Breast Section 4: Pathology of Malignant Lesions 9. In Situ Carcinomas of the Breast: Ductal Carcinoma in Situ and Lobular Carcinoma in Situ 10. Infiltrating Carcinomas of the Breast: Not One Disease 11. Mesenchymal Neoplasms and Primary Lymphomas of the Breast 12. Paget Disease of the Breast 13. Primary and Secondary Dermatologic Disorders of the Breast 14. Breast Biomarker Immunocytochemistry Section 5: Natural History, Epidemiology, Genetics, and Syndromes of Breast Cancer 15. Epidemiology of Breast Cancer 16. Primary Prevention of Breast Cancer 17. Breast Cancer Genetics: Syndromes, Genes, Pathology, Counseling, Testing, and Treatment Section 6: Prognostic Factors for Breast Cancer 18. Clinically Established Prognostic Factors in Breast Cancer 19. Molecular Prognostic Factors for Breast Carcinoma 20. Risk Factors for Breast Carcinoma in Women with Proliferative Breast Disease 21. Steroid Receptors in Breast Cancer Section 7: Molecular Biology of Breast Carcinogenesis 22. Molecular Oncology of Breast Cancer 23. Stem Cells in Breast Development and Cancer 24. Therapeutic Strategies for Breast Cancer Section 8: Screening and Diagnosis of Breast Disease 25. Examination Techniques: Roles of the Physician and Patient in Evaluating Breast Disease 26. Breast Imaging Screening and Diagnosis Section 9: Clinical Trials: Biostatistical Applications 27. Design and Conduct of Clinical Trials for Breast Cancer Section 10: Surgery for Benign and Malignant Diseases of the Breast 28. Indications and Techniques for Biopsy 29. General Principles of Mastectomy: Evaluation and Therapeutic Options 30. Halsted Radical Mastectomy 31. Modified Radical Mastectomy and Simple Mastectomy 32. Breast Conservation Therapy for Invasive Breast Cancer Section 11: Breast Reconstruction 33. Breast Reconstruction Techniques Section 12: Complications of Breast Surgery 34. Wound Care and Complications of Mastectomy 35. Quality Measures and Outcomes for Breast Cancer Surgery 36. Lymphedema in the Postmastectomy Patient: Pathophysiology, Prevention, and Management Section 13: Current Concepts and Management of Early Breast Carcinoma (Tis, Tmic, T1) 37. Assessment and Designation of Breast Cancer Stage 38. Biology and Management of Lobular Carcinoma in Situ of the Breast (Lobular Neoplasia) 39. Ductal Carcinoma in Situ 40. The New Paradigm: Oncoplastic Breast Conservation Surgery 41. Therapeutic Value of Axillary Node Dissection and Selective Management of the Axilla in Small Breast Cancers 42. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer 43. Detection and Significance of Axillary Lymph Node Micrometastases 44. Intraoperative Evaluation of Surgical Margins in Breast-Conserving Therapy 45. Surgical Management of Early Breast Cancer Section 14: Therapy for Stages 0, I, and II Breast Cancer 46. Biologic Basis of Radiotherapy of the Breast 47. Radiotherapy and Ductal Carcinoma in Situ 48. Radiotherapy and Regional Nodes 49. Postmastectomy Radiotherapy 50. Breast-Conserving Therapy for Invasive Breast Cancers 51. Partial Breast Irradiation: Accelerated and Intraoperative 52. Radiation Complications and Their Management 53. Radiation Therapy for Locally Advanced Breast Cancer: Historical Review to Current Approach 54. Adjuvant Endocrine Therapy 55. Adjuvant and Neoadjuvant Systemic Therapies for Early Stage Breast Cancer 56. Adjuvant HER2 Therapy 57. Bisphosphonates in Early Breast Cancer 58. Oncofertility Options for Young Women with Breast Cancer Section 15: Management of Advanced Local, Regional, and Systemic Disease 59. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast 60. Solitary Metastases 61. Locoregional Recurrence after Mastectomy 62. Principles of Preoperative Therapy for Operable Breast Cancer 63. Locally Advanced Breast Cancer 64. Inflammatory Breast Cancer 65. Neoadjuvant Chemotherapy and Radiotherapy 66. Detection and Clinical Implications of Occult Systemic Micrometastatic Breast Cancer 67. Management of the Intact Breast Primary in the Setting of Metastatic Disease 68. Management of Bone Metastases in Breast Cancer 69. Chemotherapy and HER2-Directed Therapy for Metastatic Breast Cancer 70. Endocrine Therapy for Breast Cancer 71. Immunologic Approaches to Breast Cancer Therapy 72. Diagnosis and Management of Pleural Metastases in Breast Cancer 73. Management of Central Nervous System Metastases in Breast Cancer 74. Management of Pericardial Metastases in Breast Cancer Section 16: Special Presentations of Breast Cancer 75. Bilateral Breast Cancer 76. Cancer of the Male Breast 77. Local Recurrence, the Augmented Breast, and the Contralateral Breast 78. Carcinoma of the Breast in Pregnancy and Lactation 79. Unknown Primary Presenting with Axillary Lymphadenopathy 80. Clinical Management of the Patient at Increased or High Risk Section 17: Survivorship, Follow-Up Care, and Rehabilitation of the Breast Cancer Patient 81. General Considerations for Follow-Up 82. Management of Menopause in the Breast Cancer Patient 83. Rehabilitation 84. Psychosocial Consequences and Lifestyle Interventions 85. Survivorship with Breast Cancer Section 18: Medical and Legal Issues Specific to the Care of Breast Cancer 86. Delayed Diagnosis of Symptomatic Breast Cancer.
  • (source: Nielsen Book Data)9780323359559 20171017
Now in a single, convenient volume, The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition covers every clinically relevant aspect of the field: cancer, congenital abnormalities, hormones, reconstruction, anatomy and physiology, benign breast disease, and more. Building upon the strengths of previous editions, this updated volume by Drs. Kirby I. Bland, Edward M. Copeland III, V. Suzanne Klimberg, and William J Gradishar, includes the latest innovations in breast cancer detection and treatment in a practical, easy-to-use format ideal for today's surgeons.Delivers step-by-step clinical guidance highlighted by superb illustrations that depict relevant anatomy and pathology, as well as medical and surgical procedures. Reflects the collaborative nature of diagnosis and treatment among radiologists, pathologists, surgeons, oncologists, and other health care professionals who contribute to the management of patients with breast disease. Offers the most comprehensive, up-to-date information on the diagnosis and management of, and rehabilitation following, surgery for benign and malignant diseases of the breast. Covers the latest developments in receptor modulation, targeted monoclonal antibodies, evolving inhibitors with triple-negative disease, and more. Discusses recent minimally invasive surgical techniques and new developments in oncoplastic breast conservation techniques. Contains significant updates to the "Management of Systemic Disease" section that reflect the latest advances in chemotherapy, hormonal resistance, and therapy. Includes links to real-time procedure videos and full-color procedural line drawings from the Klimberg Atlas of Breast Surgical Techniques on Expert Consult, providing expert visual guidance on how to execute key steps and techniques. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, images, videos (including video updates), glossary, and references from the book on a variety of devices.
(source: Nielsen Book Data)9780323359559 20171017
Book
1 online resource : illustrations (chiefly color)
  • Section 1 Structural and Molecular Bases of Ion Channel Function 1. Voltage-Gated Sodium Channels and Electrical Excitability of the Heart 2. Voltage-Gated Calcium 3. Voltage-Gated Potassium Channels 4. Structural and Molecular Bases of Cardiac Inward Rectifier Potassium Channel Function 5. Mammalian Calcium Pumps in Health and Disease 6. Structural and Molecular Bases of Sarcoplasmic Reticulum Ion Channel Function 7. Organellar Ion Channels and Transporters 8. Molecular Organization, Gating and Function of Connexin-based Gap Junction Channels and Hemichannels Section 2 Biophysics of Cardiac Ion Channel Function 9. Structure-function relations of Heterotrimetric complexes of sodium channel a and � subunits 10. Regulation of Cardiac Calcium Channels 11. Inhibition of Phosphoinositide 3-Kinase and Acquired Long QT Syndrome 12. Structural Determinants and Biophysical Properties of hERG1 Channel Gating 13. Molecular Regulation of Cardiac Inward Rectifier Potassium Channels by Pharmacological Agents 14. Cardiac Stretch-Activated Channels and Mechano-Electric Coupling 15. Biophysical Properties of Gap Junctions 16. Excitation-Contraction Coupling Section 3 Intermolecular Interactions and Cardiomyocyte Electrical Function 17. Ion Channel Trafficking in the Heart 18. Microdomain Interactions of Macromolecular Complexes and Regulation of the Sodium Channel Nav1.5 19. Fibroblast growth factor homologous factors modulate cardiac calcium channels. 20. Macromolecular Complexes and Cardiac Potassium Channels 21. Reciprocity of Cardiac Sodium and Potassium Channels in the Control of Excitability and Arrhythmias 22. The intercalated disc: A molecular network that integrates electrical coupling, intercellular adhesion and cell excitability 23. Function and dysfunction of ion channel membrane trafficking and post translational modification 24. Feedback Mechanisms for Cardiac-Specific microRNAs and cAMP Signaling in Electrical Remodeling. Section 4 Cell Biology of Cardiac Impulse Initiation and Propagation 25. Stem cell-derived nodal-like cardiomyocytes as a novel pharmacologic tool: insights from sinoatrial node development and function. 26. Gene Therapy and Biological Pacing 27. Intercellular Communication and Impulse Propagation 28. Mechanisms of normal and dysfunctional Sinoatrial Nodal Excitability and Propagation 29. Cell Biology of the Specialized Cardiac Conduction System 30. Cardiac Remodeling and Regeneration Section 5 Models of Cardiac Excitation 31. Ionic Mechanisms of Atrial Action Potentials 32. Genetic algorithms to generate dynamical complexity electrophysiological models 33. Calcium Signaling in Cardiomyocyte Models with Realistic Geometries 34. Theory of Rotors and Arrhythmias 35. Computational approaches for Accurate Rotor localization in the Human Atria 36. Modeling the aging heart Section 6 Neural Control of Cardiac Electrical Activity 37. Innervation of the sinoatrial node 38. Mechanism for altered autonomic and oxidant regulation of cardiac sodium currents. 39. Pulmonary Vein Ganglia and the Neural Regulation of the Heart Rate 40. Neural Activity and Atrial Tachyarrhythmias 41. Sympathetic Innervation and Cardiac Arrhythmias Section 7 Arrhythmia Mechanisms 42. The Molecular Pathophysiology of Atrial Fibrillation 43. Myofibroblasts, Cytokines, and Persistent Atrial Fibrillation 44. Role of the Autonomic Nervous System in Atrial Fibrillation 45. Rotors in Human Atrial Fibrillation 46. Body surface frequency-phase mapping of atrial fibrillation. 47. Panoramic Mapping of Atrial Fibrillation from the body surface 48. Mechanisms of Human Ventricular Tachycardia and Human Ventricular Fibrillation 49. Genetics of Atrial Fibrillation Section 8 Molecular Genetics and Pharmacogenomics 50. Mechanisms in Heritable Sodium Channel Diseases 51. Genetic, Ionic and Cellular Mechanisms Underlying the J Wave Syndromes 52. Inheritable Potassium Channel Diseases 53. Inheritable Phenotypes Associated With Altered Intracellular Calcium Regulation Section 9 Pharmacologic, Genetic and Cell Therapy of Ion Channel Dysfunction 54. Pharmacologic Bases of Antiarrhythmic Therapy 55. Pharmacogenomics of Cardiac Arrhythmias 56. Gene therapy to treat cardiac arrhythmias 57. Highly Mature Human iPSC-Derived Cardiomyocytes as Models for Cardiac Electrophysiology and Drug Testing 58. Cardiac repair with human induced pluripotent stem cell-derived cardiovascular cells. Section 10 DIAGNOSTIC EVALUATION 59. Assessment of the patient with a cardiac arrhythmia 60. Electrocardiography of tachyarrhythmias: Differential diagnosis of narrow and wide QRS complex tachycardias 61. Electroanatomic Mapping for arrhythmias 62. Computed tomography for electrophysiology 63. Magnetic resonance imaging for electrophysiology 64. Intracardiac echocardiography for electrophysiology 65. Exercise-induced arrhythmias 66. Cardiac monitoring: short- and long-term recording 67. Head-up Tilt Table Testing 68. Autonomic Regulation and Cardiac Risk 69. T-wave alternans 70. Noninvasive Electrocardiographic Imaging of Human Ventricular Arrhythmias and Electrophysiological Substrate 71. Genetic testing Section 11 SUPRAVENTRICULAR TACHYARRHYTHIAS: MECHANISMS, CLINICAL FEATURES, AND MANAGEMENT 72. Sinus node abnormalities 73. Atrial tachycardia 74. Atrial tachycardia in adults with congenital heart disease 75. Typical and Atypical Atrial Flutter: Mapping and Ablation 76. Atrial fibrillation 77. Preexcitation, Atrioventricular reentry, Variants 78. Electrophysiological Characteristics of Atrioventricular Nodal Reentrant Tachycardia: Implications for the Rentrant Circuits 79. Junctional tachycardia Section 12 VENTRICULAR TACHYCARRHYTHMIAS: MECHANISMS, CLNICAL FEATURES, AND MANAGEMENT 80. Premature ventricular complexes 81. Outflow tract ventricular tachycardias: Mechanisms, Clinical Features, and Management 82. Fascicular ventricular arrhythmias 83. Bundle branch reentry tachycardia 84. Ischemic heart disease 85. Ventricular Tachycardia in Patients with Dilated Cardiomyopathy 86. Ventricular Arrhythmias in Hypertrophic Cardiomyopathy 87. Ventricular Tachycardias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 88. VTs in Catcholaminergic Cardiomyopathy (Catecholaminergic polymorphic ventricular tachycardia) 89. Ventricular Arrhythmias in Heart failure 90. Arrhythmias and conduction disturbances in Non Compaction Cardiomyopathy 91. Takotsubo cardiomyopathy 92. Brugada syndrome 93. Long and short QT syndromes 94. Anderson-Tawil syndrome 95. Timothy syndrome 96. J Wave Syndromes 97. Idiopathic ventricular fibrillation 98. Sudden infant death syndrome 99. Sudden cardiac arrest/death in adults 100. Neurologic disorders 101. Drug-Induced Ventricular Tachycardia 102. Ventricular Arrhythmias in Congenital Heart Disease Section 13 SYNCOPE and Bradyarrhythmias 103. Syncope 104. Postural orthostatic tachycardia syndrome 105. Progressive conduction system disease 106. Atrioventricular block Section 14 ARRHYTHMIAS IN SPECIAL POPULATIONS PHARMACOLOGIC THERAPY 107. Sex differences in arrhythmias 108. Sudden cardiac death in athletes, inlcuding commotio cordis 109. Pediatric populations 110. Sleep-disordered breathing and arrhythmias 111. Ventricular Assist devices and Cardiac Transplantation Recipients Section 15 PHARMACOLOGIC THERAPY 112. Standard antiarrhythmic drugs 113. Innovations In Antiarrhythmic Drug Therapy 114. Nontraditional drugs for sudden cardiac death 115. Prevention of stroke in atrial fibrillation: warfarin, anti-factor Xa and thrombin drugs Section 16 CARDIAC IMPLANTABLE ELECTRONIC DEVICES 116. Implantable cardioverter defibrillators: technical aspects 117. Implantable cardioverter defibrillators: clinical aspects 118. Subcutaneous implantable defibrillator 119. Implantable pacemakers 120. Cardiac resynchronization therapy 121. Newer applications of pacemakers 122. Remote monitoring Section 17 CATHETER ABLATION 123. Catheter Ablation: Technical aspects 124. Catheter Ablation: Clinical aspects 125. Ablation for Atrial fibrillation 126. Ablation of Supraventricular tachycardias 127. Catheter Abliation for Ventricular tachycardias with/without structural heart disease 128. Epicardial and other approaches 129. Ventricular fibrillation 130. Ablation in Pediatrics 131. Congenital heart disease 132. Anesthesiology for EP procedures Section 18: SURGERY FOR ARRHYTHMIAS 133. Surgery for Atrial fibrillation and other supraventricular tachycardias 134. Surgery for Ventricular tachycardia Section 19 NEW APPROACHES 135. Cervical vagal stimulation for heart failure 136. Baroreflex stimulation 137. Spinal cord stimulation for heart failure and Arrhythmias 138. Renal artery denervation 139. Left atrial appendage occlusion/ligation.
  • (source: Nielsen Book Data)9780323447331 20170814
Rapid advancements in cardiac electrophysiology require today's health care scientists and practitioners to stay up to date with new information both at the bench and at the bedside. The fully revised 7th Edition of Cardiac Electrophysiology: From Cell to Bedside, by Drs. Douglas Zipes, Jose Jalife, and William Stevenson, provides the comprehensive, multidisciplinary coverage you need, including the underlying basic science and the latest clinical advances in the field.
(source: Nielsen Book Data)9780323447331 20170814
Book
1 online resource (356 p.) : ill. (some col.).
"Cardioprotective Natural Products: Promises and Hopes focuses on the recent advances in the research of bioactive natural products with cardioprotective potential against various cardiovascular diseases/disorders. The aim of this book is to underline the promise and future hope in bioactive natural molecules, herbal formulations, natural dietary supplements and related materials in the prevention and cure of cardiovascular diseases in a scientific way. This book, which comprises a variety of about 9 chapters written by active researchers and leading experts, brings together an overview of current discoveries and trends in this field. This volume is also an outstanding source of information with regard to the industrial application of natural products for medicinal purposes. The broad interdisciplinary approach adopted in this book ensures that it is much more interesting to scientists deeply engaged in the research and/or use of bioactive natural products. It will serve not only as a valuable resource for researchers in their own fields to predict promising leads for developing pharmaceuticals to prevent and treat disease manifestations, but will hopefully also motivate young scientists to engage in the dynamic field of natural products research."--Publisher's website.
Book
1 online resource
Keeping up with the use of new technologies in cardiology is becoming increasingly challenging. Case Studies in Clinical Cardiac Electrophysiology helps to bridge the gap between knowledge and application with 28 cases spanning both common and uncommon arrhythmias and ablation scenarios, each of which includes the clinical presentation, baseline ECG, ECG during arrhythmia, stepwise electrophysiologic diagnostic maneuvers and some of their pitfalls, and optimal therapy. Online access to the complete contents ensures the information you need is right at your fingertips.
Book
1 online resource (xii, 256 pages) : illustrations (some color).
  • PrefaceTable of Contents...Contributing Authors...Part I Introduction1. Evaluating Nanomedicines: Obstacles and AdvancementsMagdalena Swierczewska, Rachael M. Crist, and Scott E. McNeilPart II Sterility and Endotoxin Testing2. Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate TestTimothy M. Potter, Barry W. Neun, Anna N. Ilinskaya, and Marina A. Dobrovolskaia3. Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in NanoformulationsBarry W. Neun and Marina A. DobrovolskaiaPart III Physicochemical Characterization4. Elemental Analysis in Biological Matrices Using ICP-MSMatthew N. Hansen and Jeffrey D. Clogston5. PEG Quantitation Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol DetectionMackensie C. Smith and Jeffrey D. Clogston6. Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric AnalysisAlpana A. Dongargaonkar and Jeffrey D. Clogston7. Immunoelectron Microscopy for Visualization of NanoparticlesSarah R. Anderson, David Parmiter, Ulrich Baxa, and Kunio Nagashima 8. Imaging of Liposomes by Transmission Electron MicroscopyUlrich BaxaPart IV Immunology9. Updated Method for In Vitro Analysis of Nanoparticle Hemolytic PropertiesBarry W. Neun, Anna N. Ilinskaya, and Marina A. Dobrovolskaia10. In Vitro Assessment of Nanoparticle Effects on Blood CoagulationTimothy M. Potter, Jamie C. Rodriguez, Barry W. Neun, Anna N. Ilinskaya, Edward Cedrone, and Marina A. Dobrovolskaia11. In Vitro Analysis of Nanoparticle Effects on the Zymosan Uptake by Phagocytic CellsTimothy M. Potter, Sarah L. Skoczen, Jamie C. Rodriguez, Barry W. Neun, Anna N. Ilinskaya, Edward Cedrone, and Marina A. Dobrovolskaia12. Assessing NLRP3 Inflammasome Activation by NanoparticlesBhawna Sharma, Christopher B. McLeland, Timothy M. Potter, Stephan T. Stern, and Pavan P. Adiseshaiah13. Analysis of Complement Activation by NanoparticlesBarry W. Neun, Anna A. Ilinskaya, and Marina A. Dobrovolskaia 14. Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In VivoTimothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia15. Analysis of Pro-Inflammatory Cytokine and Type II Interferon Induction by NanoparticlesTimothy M. Potter, Barry W. Neun, Jamie C. Rodriguez, Anna N. Ilinskaya, and Marina A. Dobrovolskaia 16. Analysis of Nanoparticle Adjuvant Properties In VivoBarry W. Neun and Marina A. Dobrovolskaia17. In Vitro and In Vivo Methods for Analysis of Nanoparticle Potential to Induce Delayed Type Hypersensitivity ReactionsTimothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia18. Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion ConstructPavan P. Adiseshaiah, Sarah L. Skoczen, Jamie C. Rodriguez, Timothy M. Potter, Krishna Kota, and Stephan T. SternPart V Drug Release and In Vivo Efficacy19. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope TracerSarah L. Skoczen and Stephan T. Stern20. Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth InhibitionPavan P. Adiseshaiah and Stephan T. Stern.
  • (source: Nielsen Book Data)9781493973507 20171211
This second edition volume expands on the first edition by providing up-to-date protocols to characterize nanomaterials used as drug delivery agents. The chapters in this book are divided into 5 parts and cover topics such as: advances and obstacles in nanomedicine research; methods to test sterility and endotoxin, physicochemical features, immunological effects, drug release, and in vivo efficacy. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.Cutting-edge and comprehensive, Characterization of Nanoparticles Intended for Drug Delivery, Second Edition is a valuable tool for researchers and pharmaceutical and biotechnology developers who are evaluating the clinical potential of nanomedicines in preclinical studies.>.
(source: Nielsen Book Data)9781493973507 20171211
Book
1 online resource (xix, 463 pages) : color illustrations.
Book
1 online resource (xxii, 487 pages) : illustrations (some color)
  • Epidemiology of chronic coronary artery disease
  • The global perspective of ischemic heart disease
  • Genetics of coronary atherosclerosis
  • Basic mechanisms of atherosclerosis
  • Coronary microvascular dysfunction
  • Precipitants of myocardial ischemia
  • History and physical examination
  • Lipid measurements
  • Standard and novel biomarkers
  • ECG and standard exercise stress testing
  • Echocardiography
  • Nuclear imaging and pet
  • CT and MRI
  • Invasive testing
  • Putting it all together : which test for which patient?
  • Goals of therapy
  • Global risk assessment
  • Lifestyle interventions
  • Obesity and the obesity paradox
  • The medical treatment of stable angina
  • Antiplatelet and anticoagulant drugs
  • Prevention of sudden cardiac death
  • Revascularization approaches
  • Managing chronic coronary artery disease in patients with diabetes
  • Angina in patients with evidence of myocardial ischemia and no obstructive coronary artery disease
  • Depression, anxiety, and stress
  • Refractory angina
  • Primary prevention of atherosclerotic cardiovascular disease
  • Screening for atherosclerotic cardiovascular disease in asymptomatic individuals
  • Secondary prevention of coronary artery disease.
Featuring expert guidance from Drs. James de Lemos and Torbjorn Omland, as well as other globally known leaders in cardiology, Chronic Coronary Artery Disease covers every aspect of managing and treating patients suffering from chronic coronary syndromes. This brand-new companion to Braunwald's Heart Disease was designed as a stand-alone reference for physicians treating patients who present with complex, unique challenges, offering the latest information on the use of imaging modalities in diagnosis and treatment, advances in interventional and surgical approaches to revascularization, new medications to improve symptoms and outcomes in chronic CAD, and much more. Relevant updates to the text are sourced regularly from the parent reference, Braunwald's Heart Disease and delivered on Expert Consult at no additional cost. These updates cover late-breaking clinical trials, reviews of important new articles, and the latest guidance on clinical practice, all selected and masterfully edited by Dr. Eugene Braunwald.
Book
1 online resource. Digital: text file; PDF.
  • Chapter 1. Introduction and Biogeography (Jessica Halofsky, David Peterson, and Karen Dante-Wood).- Chapter 2. Climatology (Linda Joyce and Marian Talbert).- Chapter 3. Water Resources (Chales Luce).- Chapter 4. Fisheries (Michael Young and Daniel Isaak). - Chapter 5. Forest Vegetation (Robert Keane).- Chapter 6.- Non-Forest Vegetation (Matthew Reeves).- Chapter 7. Ecological Disturbance (Rachel Loehman).- Chapter 8. - Wildlife (Kevin McKelvey and Polly Buotte).- Chapter 9. Recreation (Michael Hand and Megan Lawson).- Chapter 10.- Ecosystem Services (Travis Warziniack).- Chapter 11. Cultural Resources (Carl Davis).- Chapter 12. Applications in Resource Management and Planning (Karen Dante-Wood and Linh Hoang).
  • (source: Nielsen Book Data)9783319569277 20171127
This book is the result of a team of approximately 100 scientists and resource managers who worked together for two years to understand the effects of climatic variability and change on water resources, fisheries, forest vegetation, non-forest vegetation, wildlife, recreation, cultural resources and ecosystem services. Adaptation options, both strategic and tactical, were developed for each resource area. This information is now being applied in the northern rocky Mountains to ensure long-term sustainability in resource conditions.The volume chapters provide a technical assessment of the effects of climatic variability and change on natural and cultural resources, based on best available science, including new analyses obtained through modeling and synthesis of existing data. Each chapter also contains a summary of adaptation strategies (general) and tactics (on-the-ground actions) that have been developed by science-management teams.
(source: Nielsen Book Data)9783319569277 20171127
Book
1 online resource (xi, 631 pages) : illustrations (chiefly color)
  • Preinvasive disease of the cervix / L. Stewart Massad
  • Preinvasive disease of the vagina and vulva and related disorders / Cara A. Mathews and Joan L. Walker
  • Invasive cervical cancer / Krishnansu S. Tewari and Bradley J. Monk
  • Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer / Lisa M. Landrum, Rosemary E. Zuna, and Joan L. Walker
  • Adenocarcinoma of the uterine corpus / William T. Creasman and David Scott Miller
  • Sarcoma of the uterus / D. Scott McMeekin and William T. Creasman
  • Gestational trophoblastic disease / Emma L. Barber and John T. Soper
  • Invasive cancer of the vulva / Thomas Herzog
  • Invasive cancer of the vagina / Marilyn Huang, Brian M. Slomovitz, and Robert L. Coleman
  • The adnexal mass / Camille C. Gunderson, Robert S. Mannel, and Philip J. Di Saia
  • Epithelial ovarian cancer / Eric L. Eisenhauer, Ritu Salani, and Larry J. Copeland
  • Germ cell, stromal, and other ovarian tumors / Emily R. Penick, Chad Hamilton, G. Larry Maxwell, and Charlotte S. Marcus
  • Fallopian tube cancer / Erica R. Hope, G. Larry Maxwell, and Chad A. Hamilton
  • Breast diseases / Patricia A. Cronin and Mary L. Gemignani
  • Cancer in pregnancy / Krishnansu S. Tewari
  • Complications of disease and therapy / Kemi M. Doll, Daniel L. Clarke-Pearson
  • Basic principles of chemotherapy / Christina S. Chu and Stephen C. Rubin
  • Targeted therapy and molecular genetics / Shannon N. Westin, Anil K. Sood, and Robert L. Coleman
  • Genes and cancer : genetic counseling and clinical management / David G. Mutch, Sheri Babb, and Philip J. Di Saia
  • Palliative care and quality of life / Dana M Chase, Siu-Fun Wong, Lari Wenzel, and Bradley J. Monk
  • Role of minimally invasive surgery in gynecologic malignancies / Floor J. Backes, David E. Cohn, Robert S. Mannel, and Jeffrey M. Fowler
  • Epidemiology of commonly used statistical terms and analysis of clinical studies / Wendy R. Brewster
  • Basic principles in gynecologic radiotherapy / Catheryn M. Yashar
  • Appendices. Staging: staging of cancer at gynecologic sites
  • Modified from common terminology criteria for adverse events (common terminology criteria for adverse events)
  • Blood component therapy
  • Suggested recommendations for routine cancer screening
  • Nutritional therapy.
The most readable, most comprehensive book in its field, Clinical Gynecologic Oncology, 9th Edition is the leading reference for diagnosis and treatment of gynecologic cancers - a must-have reference for improving outcomes and providing effective care. A "who's who" list of contributing authors, under the editorial direction of Drs. Philip DiSaia and William Creasman, provides expert guidance on clinical presentations and management, now fully up to date with a brand-new design for faster, easier reference.
(source: Nielsen Book Data)9780323400671 20170410
Book
1 online resource.
  • Contents Contributing authors Preface Tribute Acknowledgements Part I Introduction 1 History 2 Anterior eye 3 Visual optics Part II Soft contact lenses 4 Soft lens materials 5 Soft lens manufacture 6 Soft lens optics 7 Soft lens measurement 8 Soft lens design and fitting 9 Soft toric lens design and fitting 10 Soft lens care systems Part III Rigid contact lenses 11 Rigid lens materials 12 Rigid lens manufacture 13 Rigid lens optics 14 Rigid lens measurement 15 Rigid lens design and fitting 16 Rigid toric lens design and fitting 17 Rigid lens care systems Part IV Lens replacement modalities 18 Daily disposable soft lenses 19 Reusable soft lenses 20 Planned replacement rigid lenses Part V Special lenses and fitting considerations 21 Scleral lenses 22 Tinted lenses 23 Presbyopia 24 Extended wear 25 Sport 26 Keratoconus 27 High ametropia 28 Babies and children 29 Therapeutic applications 30 Post-refractive surgery 31 Post-keratoplasty 32 Orthokeratology 33 Myopia control 34 Diabetes Part VI Patient examination and management 35 History taking 36 Diagnostic instruments 37 Preliminary examination 38 Patient education 39 Aftercare 40 Complications 41 Digital imaging 42 Compliance 43 Practice management Appendices A Contact lens design and specifications B Contact lens tolerances C Vertex distance correction D Corneal curvature - corneal power conversion E Extended keratometer range conversion F Soft lens average thickness G Soft lens oxygen performance H Constant edge clearance rigid lens designs I Soft toric lens misalignment demonstrator J Dry eye questionnaire K Efron grading scales for contact lens complications L Scleral lens fit scales Index.
  • (source: Nielsen Book Data)9780702066603 20170814
In this thoroughly revised and updated third edition of Contact Lens Practice, award-winning author, researcher and lecturer, Professor Nathan Efron, provides a comprehensive, evidence-based overview of the scientific foundation and clinical applications of contact lens fitting. The text has been refreshed by the inclusion of ten new authors - a mixture of scientists and clinicians, all of whom are at the cutting edge of their specialty. The chapters are highly illustrated in full colour and subject matter is presented in a clear and logical format to allow the reader to quickly hone in the desired information.
(source: Nielsen Book Data)9780702066603 20170814
Book
1 online resource.
  • Chapter 1: Pathophysiology of atherosclerosis Biology of the vessel wall Endothelial function Atherosclerotic plaque Risk factors (dyslipidemia, smoking, hypertension etc.) The role of inflammation The role of oxidative stress Genetics of atherosclerosis Chapter 2: Coronary artery circulation: Basic principles Functional anatomy Myocardial oxygen consumption Regulation of oxygen transport and coronary blood flow Stable angina pectoris Acute coronary syndromes Chapter 3: Novel and experimental therapies in advance atherosclerosis Anti-inflammatory treatments Anti-oxidant treatment Gene-therapy Stem-cell therapy Diagnostic strategies-novel imaging modalities-multimodalities and hybrid techniques Novel antiplatelet agents Primary percutaneous coronary intervention Novel developments in interventional strategies.
  • (source: Nielsen Book Data)9780128119082 20171204
Coronary Artery Disease: From Biology to Clinical Practice links the most important basic concepts of atherosclerosis pathophysiology to treatment management of coronary artery disease. Comprehensive coverage starts with the basic pathophysiologic mechanisms of the disease, including molecular and genetic mechanisms, cells interaction and inflammation. In addition, sections on novel anti-atherosclerotic therapies and a thorough understanding of the recent trends in clinical management round out this comprehensive tome that is ideal for practitioners and researchers. By summarizing this novel knowledge and changes in diagnostic algorithm and treatment options, this is the perfect reference for cardiology researchers who want a volume with the most up-to-date experimental trends in the field of atherosclerosis, for cardiologists and physicians who manage patients with atherosclerotic risk factors and established coronary artery disease, and medical students who want to learn the basic concepts of atherosclerosis.
(source: Nielsen Book Data)9780128119082 20171204
Book
1 online resource (xii, 795 pages) : illustrations.
  • 1 The Aging Face-- 2 Diagnosis of the Cosmetic Facial Surgery Patient: The Art of the Consult and the Office Patient Experience-- 3 Facelift Surgery (Cervicofacial Rhytidectomy)-- 4 Brow and Forehead Lift-- 5 Cosmetic Blepharoplasty-- 6 Rhinoplasty-- 7 Facial implants-- 8 Cosmetic Otoplasty and Related Cosmetic Ear Surgery-- 9 Neuromodulators (neurotoxins) in Cosmetic Facial Surgery-- 10 Lip Augmentation with Injectable Fillers, Lip Reduction & Lip Lift-- 11 Lip Anatomy and Histology-- 12 Lifetime skincare-- 13 Laser skin resurfacing-- 14 Chemical peel-- 15 Management of Cervicofacial Fat.
  • (source: Nielsen Book Data)9780323393935 20170410
Bring your practice fully up to date with the most effective and innovative techniques in cosmetic facial surgery! The 2nd Edition of Dr. Joe Niamtu's practical resource covers everything from new implants, lasers, blepharoplasty, and liposuction technologies to innovative new procedures that will greatly benefit your patients. In this fully revised edition, you'll learn not only from Dr. Niamtu, but also from other internationally recognized cosmetic surgeons in plastic surgery, facial plastic surgery, oral and maxillofacial surgery, oculoplastic surgery, and dermatology. Additionally, virtually every image and illustration has been revised to provide a thoroughly up-to-date visual guide suitable for everyday reference.
(source: Nielsen Book Data)9780323393935 20170410
Book
xvii, 1087 pages : illustrations (chiefly color) ; 28 cm
Medical Library (Lane)
Book
1 online resource (192 pages).